Log In
BCIQ
Print this Print this
 

ReLASV Antigen Rapid Test

  Manage Alerts
Collapse Summary General Information
Company Zalgen Labs LLC
DescriptionTest that detects Lassa virus antigen in blood
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationViral hemorrhagic fever
Indication DetailsDiagnose Lassa viral hemorrhagic fever
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/22/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today